ABSTRACT The classification of MAP 2 as a microtubule-associated protein is based on its affinity for microtubules in vitro and its filamentous distribution in cultured cells. We sought to determine whether MAP 2 is also able to bind in situ to organelles other than microtubules. For this purpose, primary cultures of rat brain cells were stained for immunofluorescence microscopy with a rabbit anti-MAP 2 antibody prepared in our laboratory, as well as with antibodies to vimentin, an intermediate filament protein, and to tubulin, the major subunit of microtubules. MAP 2 was present on cytoplasmic fibers in neurons and in a subpopulation of the flat cells present in the cultures. Our observations were concentrated on the flat cells because of their suitability for high-resolution immunofluorescence microscopy. Double antibody staining revealed co-localization of MAP 2 with both tubulin and vimentin in the flat cells. Pretreatment of the cultures with vinblastine resulted in the redistribution of MAP 2 into perinuclear cables that contained vimentin. Tubulin paracrystals were not stained by anti-MAP 2. In cells extracted with digitonin, the normal fibrillar distribution of MAP 2 was resistant to several treatments (PIPES buffer plus 10 mM Ca ++, phosphate buffer at pH 7 or 9) that induced depolymerization of microtubules, but not intermediate filaments. Staining of the primary brain cells was not observed with preimmune serum nor with immune serum adsorbed prior to use with pure MAP 2. We detected MAP 2 on intermediate filaments not only with anti-MAP 2 serum, but also with affinity purified anti-MAP 2 and with a monoclonal anti-MAP 2 prepared in another laboratory. We conclude from these experiments that material recognized by anti-MAP 2 antibodies associates with both microtubules and intermediate filaments. We propose that one function of MAP 2 is to cross-link the two types of cellular filaments.
phosphorylates MAP 2 (55, 60) . Presumably, the projection domain also contains a site or sites for binding of other cytoplasmic organdies.
Evidence for the binding of MAP 2 in vitro to actin filaments, coated vesicles, and intermediate filaments has been reported (1, 24, 34, 40, 45, 46) . While these studies have identified structures that are capable of interacting with MAP 2 in vitro, they leave open the question of which organelles actually bind MAP 2 in cells. We initiated our study to resolve this question and to further our characterization of the binding domains of this protein. We reasoned that if the cellular microtubule binding site for MAP 2 were dissolved it might be possible to identify other organelles to which the MAP bound. We chose to work with primary cultures of brain ceils because these cells contain MAP 2 in apparently high concentration and include a population of well-spread cells that are suitable for highresolution immtmocytochemical techniques (27, 41) . We report that, after dissolution of microtubules, MAP 2 is found in association with intermediate f'daments, indicating a role for MAP 2 in mediating the interaction of microtubules with this other class of cellular filament.
MATERIALS AND METHODS

Anti-MAP 2 Antibodies:
We prepared a rabbit antibody to calf brain MAP 2 in this laboratory, and used it to immunoprecipitate the MAP 2 protein kinase complex (55) and to localize MAP 2 by immunofluorescence in the rat central nervous system (35) (Miller, P., W. E. Theurkauf, R. B. Vallee, and P. De CAmilli, manuscript in preparation). The MAP 2 immunogen was purified by a three-step process designed to insure antigen purity. First, callbrain microtubules were purified by four cycles of assembly and disassembly in the absence of glycerol (60) . The microtubules were exposed to elevated temperatures (90-100°C) to coagulate tubulin, MAP l, and a variety of minor polypeptides species (18, 25, 30) . The MAP 2-enriched soluble fraction was finally subjected to preparative SDS PAGE. After staining with Coomassie Brilliant Blue R250, the MAP 2 doublet (30) was excised from the gel and homogenized with Freund's complete adjuvant. A rabbit was injected subcutaneously with ~ 100 #g of MAP 2 on each of three occasions, and was bled 1 wk after the final injection. Affinity-purified anti-MAP 2 was prepared by passage of the immune serum over a MAP 2-Sepharose 4B column. The MAP 2 used here was prepared from twice-cycled calf brain microtubules by exposure to elevated temperature (see above). The protein was conjugated to CNBr-activated Sepharose 4B, and monospecific anti-MAP 2 was eluted from the column with 200 mM glycine at pH 2.7 (20).
Monoclonal mouse anti-porcine brain MAP 2 (27) Guinea pig antitubulm was prepared in this laboratory. The immunogen was purified by three cycles of assembly and disassembly of calf brain microtubules (60), chromatography on DEAE Sephadex A-50 (59) and preparative SDS PAGE. The tubulin band was homogenized in phosphate-buffered saline (PBS) and emulsified with Freund's Complete Adjuvant. The animal was injected at four subcutaneous sites with ~700/~g of tubulin on each of eight occasions spaced 1-2 wk apart. A terminal bleed was performed 1 wk after the final injection of tubulm.
The following were purchased from Cappel Laboratories (Cochranville, PA): rhodamine-conjugated IgG fractions of sheep and goat anti-rabbit IgG, fluorescein-conjugated IgG fraction of goat anti-guinea pig IgG, and sheep antiserum to goat IgG. The IgG fraction of this antiserum was labeled with fluorescein as described (19) to an average molar ratio of fluorescein:lgG of 2.6. Fluoresceinlabeled goat anti-mouse IgG was acquired from Meloy Laboratories (Springfield, VA).
Primary Rat Brain Cultures:
Features ofscvcral published protocols (8, 66, 67) were adapted to produce cultures with optimal survival of cells found to contain MAP 2. Whole brains from rats varying in age from 16-d fetuses to ld postnatal were used. The cultures were grown on glass coverslips in 35-ram petri dishes. The coverslips were coated with a 1:3 mixture of l mg/ml poly-Llysine (Sigma Chemical Co., St. Louis, MO; Type VII-B, 35,000 tool wt): fctai 1524 THE lOUeNAt OF CELL BIOLOGY. VOLUME 96, 1983 call serum. Each brain yielded enough ceils for six 22-ram 2 coverslips.
Freshly dissected brains were rinsed twice in Hanks' balanced salt solution (MA Biologicals, Walkersville, MD) and minced as finely as possible with a scalpel in 2 ml of 0.25% trypsin (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY). An additional 8 ml of trypsin solution was then added, and the minced tissue was triturated gently five times with a 10-ml pipette. This suspension was stirred at 37°C for 15 min, at which time 10 ml of high serum medium was added (43% each F-12 and Dulbecco's MEM, 8% horse serum, 5% fetal call serum, penicillin, streptomycin; all from Gibco Laboratories). The suspension of single cells and small clumps of tissue was triturated gently another five times, and was centrifuged for 5 rain at 1,500 g. The pellet was resuspendcd in high serum medium by gentle trituration, and 2.5 ml of cell suspension was added to each coverslip. The dishes were then placed in a 37°C-incubator containing an atmosphere of 95% air, 5% CO2. After 2 h, the medium was aspirated and each dish was fed with 2.5 ml of N2 defined medium (7) supplemented with 2% fetal calf serum, penicillin, and streptomycin. The cultures were ready for use within 3 or 4 d, and could be maintained for several weeks if fed every 3 or 4 d with the N2-based medium.
Indirect Immunofluorescence Microscopy: CeiLs to be stained for cytoskeletal proteins were processed in the following manner. Coverslips were rinsed twice for 30 s with PBS at 37°C. A 5-rain methanol fLxation at -20°C was performed either immediately following the PBS rinses, or after a subsequent 2-rain extraction of the cells in PEM buffer (100 mM PIPES, 1 mM EGTA, 1 mM MgSO4) containing 0.005% digitonin (Sigma Chemical Co.). The coverslips were rehydrated with PBS and incubated with 10% nonspecific serum obtained from the same animal species as the fluorescent antibodies. 10% serum was aLso included in subsequent antibody incubations. All antibodies were diluted in PBS, and were applied to the ¢overslips for 30 min each at 37°C in humidified chambers. Rabbit anti-MAP 2 serum was used at a final concentration of 1.0-1.3%. Affinity-purified rabbit anti-MAP 2 was used at 8-16 #g/ml. For some experiments, rabbit anti-MAP 2 was used in combination with goat or guinea pig antitubulin, or with monoclonal mouse antibodies to vimentin or MAP 2. Fluorescent anti-IgG antibodies were used alone or in various combinations, as indicated in the figure legends. Thorough PBS washes were performed after each antibody step. After the final PBS wash, the coverslips were rinsed with distilled water and sealed to slides with elvanol (22) .
For the tetanus toxin experiment, live cells were incubated for 30-rain periods at 37°C in three changes of medium containing, sequentially, 10 #g/ml tetanus toxin, goat anti-tetanus toxin, and fluorescein-sheep anti-goat lgG. A brief PBS rinse followed each step. The cells were then fLxed in methanol, and stained with rabbit anti-MAP 2 and rhodamine-sheep anti-rabbit IgG, as described above.
We observed slides on a Zeiss IM-35 inverted microscope equipped with an epifluorescent illuminator, ftuorescein and rhodamine filters, and the following Zeiss oil immersion objectives: 40x phase 3 NA 1.0 Apochromat, 63x phase 3 NA 1.4 Pianapochromat.
Antibody Staining of Nitrocellulose Transfers:
Electrophoresis of protein samples was performed according to the Laemmli (32) method on 1.5-mm thick 7% polyacrylamide geLs. Electrophoretic transfer of proteins was performed by the technique of Towbin et al. (56) modified as follows for efficient transfer of high molecular weight polypeptides. After electrophoresis, the gels were soaked for 30 rain in 0.125 M Tris, pH 6.8, 0.1% SDS, 1 mM EDTA, 10 mM 2-mercaptoethanol and then transferred to nitrocellulose sheets in 0.0125 M Tris, pH 8.5, 0.096 M glycine, 0.01% SDS, 10 mM 2-mercaptoethanoL The transfer was performed for 16 h at room temperature, with a noncommercial transfer apparatus and a Pharmacia DPS destainer power supply (Pharmacia Fine Chemicals, Piscataway, N J) at a constant 36 V and a current that varied from 1 to 3 A. This resulted in at least 90% transfer of MAP 2.
Following transfer, the nitrocellulose sheet was incubated for 30 rain in staining buffer (0.05 M Tris, pH 7.4, 0.15 M NaC1, 0.05% Nonidet P-40, 0.25% bovine serum albumin-Sigma Fraction V). The paper was then stained for 3 h each with rabbit anti-MAP 2 followed by rhodamine-goat anti-rabbit IgG. Antibodies were diluted in staining buffer, which was used to wash the paper thoroughly after each antibody step. Fully dried nitrocellulose sheets were illuminated in a darkened room with a pair of ultraviolet lamps (Model UVL-2 l; Ultra-Violet Products, Inc., San Gabriel, CA), and photographs were taken through a yellow Wratten No. 15 gelatin filter (Eastman Kodak) with Polaroid Type 55 P/N film.
RESULTS
Characterization of Anti-MAP 2
Partial characterization of our anti-MAP 2 antibody has been reported elsewhere (35; Miller, P., W. E. Theurkauf, R. B. Vallee, and P. De Camilli, manuscript in preparation). The antibody stained neurons in sections of mature rat brain, and showed particularly bright staining of neuronal dendrites. The antibody specifically stained a protein of the molecular weight of MAP 2 in whole brain, purified microtubules, and purified preparations of MAP 2. For the present study, we examined newborn rat brain tissue by immunocytochemical means (Fig.  1) . It may be observed that only a band at the position of MAP 2 reacts with the anti-MAP 2 antiserum.
Immunofluorescent Detection of M A P 2 in Primary Cultures of Rat Brain Cells
The primary cultures of rat brain cells used in this study contained a variety of morphologically distinct ceils. When these cultures were reacted with anti-MAP 2 antibody, only selected ceils were stained. Fig. 2a and b illustrate the most common MAP 2-positive cells. These cells had a neuronal morphology, with small soma (10-25 /tm diameter) and numerous free processes that occasionally extended for >100 #m. The processes frequently exhibited periodic varicosities. In favorable images, distinct fluorescent fibrils were visible in large, neuronlike cells (Fig. 2c) . Almost all MAP 2-positive neuronlike cells were found to possess tetanus toxin receptors (not shown) and were probably neurons, therefore (16, 36) . In addition to containing cells of neuronal morphology, the cultures also contained an abundance of fiat, well-spread cells, some of which stained with anti-MAP 2 (Fig. 2 d) . The staining of such cells was always found on networks of gently curving cytoplasmic fibrils, whose appearance resembled microtubules or 10-rim filaments. These cells were negative for tetanus toxin receptors (not shown), and their identity is not known at present. We observed both MAP 2-positive cell types whether unfractionated anti-MAP 2 antiserum, affinity-purified anti-MAP 2, or monoclonal anti-MAP 2 was used. Examples of such staining may be observed throughout this paper (Figs. 2-8) . No specific staining of either the neurons or flat cells was detected with antiserum preadsorbed with the purified MAP 2 that was used as the immunogen, or with preimmune serum (not shown).
Co-localization of M A P 2 and Tubulin
The MAP 2-positive flat cells provided an excellent experi-BLOOM AND VALLEE mental system for high-resolution, immunofluorescent location of MAP 2, which was not possible with the more compact neurons. Therefore, our observations focused on the fiat subpopulation of cells, as described in the remainder of the paper. To determine whether MAP 2 co-localized with microtubules, the cultures were stained simultaneously with anti-MAP 2 and antitubulin. An example of a fiat, MAP 2-positive cell stained also with antitubulin is shown in Fig. 3 a and b . Extensive colocalization of the two antigens on cytoplasmic fibers was observed. Dividing MAP 2-positive cells were occasionally found. We observed co-localization of MAP 2 and tubulin throughout mitosis and cytokinesis (Fig. 3 c-f) .
Uncoupling of MAP 2 -Tubulin Co-Localization
The anti-MAP 2 staining patterns shown in Fig. 3 are characteristic of microtubules. To determine the cellular location of MAP 2 in the absence of microtubules, we employed two approaches. First, the cultures were exposed to vinblastine sulfate for several hours prior to fixation and antibody staining. Antitubulin staining (not shown) revealed the absence of microtubules in the fiat ceils, and the appearance of brightly staining tubulin paracrystals, as is characteristic of cells exposed to this drug. Thin-section electron microscopy of these cultures similarly revealed the complete absence of microtubules (not shown). Fig. 4 shows an example of a flat cell that showed positive staining with anti-MAP 2. The single, striking paracrystal in this cell was readily detected by phase-contrast microscopy (Fig. 4a) . However, the antibody conspicuously failed to stain the paracrystal. Instead, a sinuous cable of bright fluorescence surrounding the nucleus was observed (Fig. 4 b) . This pattern of staining was clearly not consistent with that found for tubulin. Rather, it was consistent with that expected for certain classes of intermediate filaments. An intermediate fdamentlike distribution of MAP 2 was also observed in ceils exposed to colchicine (not shown), and was apparent with vinblastine or colchicine incubations ranging from 1 to 24 h. Thus, our results appeared to reveal a second binding site for MAP 2 in cells, one associated with intermediate filaments.
As an independent approach to eliminate microtubules, the primary brain cells were extracted with digitonin under conditions known to result in the disassembly of microtubules. The cells were then fixed and double-stained for tubulin and MAP 2, as shown in Fig. 5 . MAP 2 and tubulin co-localized on cytoplasmic fibrils in cells extracted with PIPES buffer (Fig.  5a and b) , which preserves microtubules. Both phosphate buffers (Fig. 5 f and h ) and PIPES buffer with 10 mM Ca ++ (Fig. 5d) dissolved microtubules, as judged by antitubulin staining. However, the same cells still exhibited a fibrillar pattern of staining with anti-MAP 2 ( Fig. 5 c, e, and g ), indicating the existence of a nonmicrotubule binding site for MAP 2 in these cells. The fibrillar nature of the staining pattern and its stability in the extracted cells is again consistent with localization of MAP 2 on intermediate filaments.
Co-localization of M A P 2 and Vimentin
To determine directly whether MAP 2 co-localized with intermediate filaments, cells were double-stained with antibodies to vimentin and MAP 2 (Fig. 6) . Extensive co-localization of MAP 2 and vimentin on cytoplasmic fibrils was observed. In vinblastine-treated cultures (Fig. 7) , we again observed co-localization of vimentin and MAP 2, but now on cables characteristic of intermediate filaments in cells exposed to the drug. 
Comparison of Polyclonal and Monoclonal Anti-MAP2
To determine whether the results obtained were unique to our anti-MAP 2 antibody preparation, vinblastine-treated cells were double-labeled with our polyclonal rabbit antibody and a monoclonal antibody prepared by Izant and McIntosh (27) . The results of this comparison are shown in Fig. 8 . It is clear that both antibody preparations stained intermediate filament cables, but not tubulin paracrystals, in the flat primary brain cells.
D I S C U S S I O N
MAP 2 has been classified as a MAP primarily on the basis of its affinity for microtubules in vitro (4, 38, 53) . In addition, antibodies to this protein have been found to stain cytoplasmic fibers in a limited number of cultured cell types (27, 31, 41, 57) . The conclusion that these fibers were microtubules was based on co-localization of the immunoreactive species with 1526 TNE JOURNAL OF CELL BIOLOGY" VOLUME 96, 1983 tubulin (27) and abolition of the fibrous staining pattern by antimicrotubule drugs (27, 31) . Here we report that in cultured brain cells an anti-MAP 2 antibody stained fibrils that colocalized with both microtubules (see Fig. 3 
Specificity of the Anti-MAP 2 Antibody
It is possible that these results simply reflect the presence in our anti-MAP 2 preparation of contaminating antibodies specific for an intermediate fdament protein. We consider this quite unlikely since both affinity purified anti-MAP 2 (see Fig.  4 b) and an independently prepared monoclonal anti-MAP 2 (see Fig. 8 b) stained intermediate filaments. In addition, nei- ther immune serum adsorbed prior to use with pure MAP 2, nor preimmune serum-stained cytoplasmic fdaments.
This indicates that the intermediate filament-associated antigen recognized by anti-MAP 2 is truly cross-reactive with MAP 2. Nonetheless, it is possible that this antigen represents a protein quite distinct from MAP 2, but which is immunologicaUy cross-reactive due to limited amino acid sequence homology. Several examples of distinct, but immunologically cross-reactive cytoskeletal proteins have been reported (3, 5, 39, 42) . Indeed, it has been found that MAP 2 itself reacts with an antispectrin antibody (15).
Thus, it is possible that we have identified an intermediate fdament protein which shares one or more antigenic sites with MAP 2, but is otherwise distinct. However, several considerations lead us to believe that MAP 2 itself is the antigen associated with intermediate fdaments. First, the only antigenic species detected by our antibody in a mixture of total newborn rat brain proteins has a mobility in SDS PAGE identical to that of MAP 2 (see Fig. 1 ). Second, the antibody stained only a limited number of the fiat cells in these cultures (10% or less). Among these cells, unambiguous staining of microtubules was observed during mitosis, while intermediate filaments were clearly stained after vinblastine treatment. Thus, if two distinct, cross-reactive proteins exist in primary brain cells, both would be present in the same small subpopulation of fiat cells. While such a coincidence is conceivable, it seems highly unlikely. Finally, we also observed co-localization of MAP 2 with both Although other laboratories have used anti-MAP 2 antibodies for immunofluorescence microscopy on cultured ceils (27, 31, 41, 57) , the association of MAP 2 with intermediate filaments has not been reported until now. Detection of this association may depend on the use of an appropriate combination of cultured cell system and experimental protocols. Indeed, we demonstrate here that a monoclonal anti-MAP 2 antibody (27) independently prepared in another laboratory can stain intermediate fdaments in our vinblastine-treated primary brain cells (see Fig. 8 ).
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Intracellular Functions of MAP 2
Immunocytochemical, electron microscopic, and physiological evidence (2, 17, 21, 26, 33, 44, 47) have pointed to an association between microtubules and intermediate fdaments.
In particular, double immunofluorescence microscopy has revealed extensive co-localization of microtubules with desmin fdaments in chicken gizzard cells (21) , with vimentin f'daments in fibroblasts (2) and with glial filaments in primary astrocytes (G. S. Bloom, R. B. Vallee, and R. Liem, unpublished observations). These findings suggest that microtubules and intermediate fdaments may be commonly connected to one another in cells, presumably by cross-linking proteins.
Recently, Wiche and co-workers (43, 64) proposed that a high molecular weight MAP-like protein cross-links microtubules and intermediate fdaments in numerous varieties of cultured ceils. However, subsequent studies in the same laboratory revealed that the protein, now known as "plectin," has an intracellular distribution that is markedly distinct from microtubules and intermediate t'daments (65) . Therefore, we feel it is unlikely that plectin acts as a cross-linker. In contrast, our finding that MAP 2 can co-localize with both microtubules and intermediate filaments indicates that this protein, in particular, is responsible for the observed interactions of the two classes of cytoplasmic fibers. Since MAP 2 may not be universally distributed in cells (27, 41, 57) , it is possible that other unidentified proteins also serve this function.
Although MAP 2 was found to be co-distributed with vimentin, we do not know whether vimentin is the only intermediate filament protein in the MAP 2-positive, fiat brain cells. Received for publication 9 November 1982 , and in revised form 4 February 1983. 
